Pediatrics

Repeated low-level red light shows greater 12-month efficacy than 1% atropine in myopia control trial

Repeated low-level red light (RLRL) therapy slowed myopia progression more than 1% atropine over 12 months, but showed slightly greater rebound in axial length after treatment stopped. The prospective, single-blinded study enrolled 136 myopic children aged 6-12 years who were randomly assigned to receive RLRL therapy or 1% atropine in...